Grape King Bio Past Earnings Performance
Past criteria checks 2/6
Grape King Bio ha aumentado sus ingresos a un ritmo medio anual de 2.5%, mientras que la industria Personal Products ha visto aumentar sus ingresos growing a 16.2% anualmente. Los ingresos han crecido growing a un ritmo medio anual de 3.2%. Grape King Bio La rentabilidad de los fondos propios de la empresa es de 19.5% y sus márgenes netos son de 13.8%.
Key information
2.9%
Earnings growth rate
0.4%
EPS growth rate
| Personal Products Industry Growth | 13.9% |
| Revenue growth rate | 3.5% |
| Return on equity | 18.4% |
| Net Margin | 13.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Grape King Bio (TPE:1707) Knows How To Allocate Capital
Apr 06
Here's Why Grape King Bio (TPE:1707) Can Manage Its Debt Responsibly
Mar 22Grape King Bio's (TPE:1707) Anemic Earnings Might Be Worse Than You Think
Mar 06How Much Did Grape King Bio's(TPE:1707) Shareholders Earn From Share Price Movements Over The Last Year?
Feb 27Grape King Bio (TPE:1707) Seems To Use Debt Quite Sensibly
Nov 20Revenue & Expenses BreakdownBeta
How Grape King Bio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 10,635 | 1,453 | 5,747 | 290 |
| 30 Sep 23 | 10,559 | 1,456 | 5,776 | 280 |
| 30 Jun 23 | 10,501 | 1,454 | 5,745 | 287 |
| 31 Mar 23 | 10,558 | 1,501 | 5,739 | 281 |
| 31 Dec 22 | 10,391 | 1,457 | 5,639 | 290 |
| 30 Sep 22 | 10,186 | 1,426 | 5,493 | 291 |
| 30 Jun 22 | 10,097 | 1,363 | 5,502 | 288 |
| 31 Mar 22 | 9,879 | 1,304 | 5,301 | 288 |
| 31 Dec 21 | 9,798 | 1,300 | 5,252 | 292 |
| 30 Sep 21 | 9,623 | 1,281 | 5,154 | 285 |
| 30 Jun 21 | 9,387 | 1,283 | 5,020 | 279 |
| 31 Mar 21 | 9,131 | 1,242 | 4,924 | 268 |
| 31 Dec 20 | 9,168 | 1,272 | 4,979 | 253 |
| 30 Sep 20 | 9,138 | 1,279 | 4,972 | 236 |
| 30 Jun 20 | 9,082 | 1,280 | 4,971 | 223 |
| 31 Mar 20 | 9,234 | 1,309 | 5,065 | 207 |
| 31 Dec 19 | 9,239 | 1,309 | 5,041 | 190 |
| 30 Sep 19 | 9,193 | 1,288 | 4,956 | 181 |
| 30 Jun 19 | 9,303 | 1,323 | 4,924 | 176 |
| 31 Mar 19 | 9,265 | 1,298 | 4,888 | 178 |
| 31 Dec 18 | 9,183 | 1,295 | 4,795 | 185 |
| 30 Sep 18 | 9,302 | 1,331 | 4,958 | 180 |
| 30 Jun 18 | 9,325 | 1,322 | 5,101 | 174 |
| 31 Mar 18 | 9,317 | 1,353 | 5,234 | 164 |
| 31 Dec 17 | 9,388 | 1,352 | 5,451 | 160 |
| 30 Sep 17 | 9,130 | 1,295 | 5,409 | 146 |
| 30 Jun 17 | 9,183 | 1,298 | 5,495 | 131 |
| 31 Mar 17 | 9,180 | 1,272 | 5,563 | 120 |
| 31 Dec 16 | 9,185 | 1,297 | 5,571 | 114 |
| 30 Sep 16 | 8,667 | 1,219 | 5,343 | 107 |
| 30 Jun 16 | 8,099 | 1,148 | 5,032 | 103 |
| 31 Mar 16 | 7,606 | 1,097 | 4,710 | 97 |
| 31 Dec 15 | 7,248 | 1,052 | 4,474 | 99 |
| 30 Sep 15 | 6,995 | 1,035 | 4,316 | 97 |
| 30 Jun 15 | 6,777 | 1,019 | 4,196 | 93 |
| 31 Mar 15 | 6,548 | 986 | 4,047 | 82 |
| 31 Dec 14 | 6,283 | 942 | 3,877 | 84 |
| 30 Sep 14 | 6,038 | 907 | 3,692 | 98 |
| 30 Jun 14 | 5,913 | 867 | 3,632 | 106 |
| 31 Mar 14 | 5,797 | 857 | 3,610 | 111 |
| 31 Dec 13 | 5,639 | 836 | 3,561 | 92 |
| 30 Sep 13 | 5,438 | 745 | 3,545 | 74 |
| 30 Jun 13 | 5,213 | 695 | 3,424 | 64 |
Beneficios de calidad: 1707 tiene ganancias de alta calidad.
Creciente margen de beneficios: 1707Los actuales márgenes de beneficio netos de (13.8%) son inferiores a los del año pasado (14%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Tendencia de beneficios: 1707Los beneficios de la empresa han crecido un 2.5% al año en los últimos 5 años.
Acelerando crecimiento: 1707's ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: 1707 tuvo un crecimiento negativo de los beneficios (-0.3%) durante el año pasado, lo que dificulta la comparación con la media del sector Personal Products (18.9%).
Return on Equity
Alto ROE: El Retorno sobre el capital de 1707 (19.5%) se considera bajo.